What are Zevra Therapeutics, Inc.'s profit margins?

Zevra Therapeutics, Inc. (ZVRA) runs a 86.1% gross margin and a -103.9% operating margin, with a 101.6% net margin.

Where do Zevra Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Zevra Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Zevra Therapeutics, Inc. ZVRA Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	84.5%+15.9pp	68.6%-20.7pp	89.3%-8.5pp	97.8%+5.0pp
Net margin	78.2%+525pp	-446.9%-279pp	-167.7%—	——
EBITDA margin	-50.3%+291pp	-341.4%-164pp	-177%+233pp	-409.6%-438pp
Returns
Return on equity	85.7%+294pp	-207.8%-141pp	-67.2%—	——
Return on assets	36%+96.2pp	-60.2%-28.2pp	-32%—	——
Return on invested capital	-49.9%+141pp	-191.1%+85.5pp	-276.6%—	——
Efficiency
Asset turnover	0.5×+0.3×	0.1×-0.1×	0.2×+0.1×	0.1×-0.3×
Inventory turnover	2.8×+2.1×	0.7×+0.2×	0.6×—	——
Liquidity
Current ratio	5.7×+3.2×	2.5×+1.3×	1.2×-6.5×	7.7×-19.5×
Quick ratio	5.7×+3.5×	2.2×+1.2×	1×-6.6×	7.7×-19.5×
Cash ratio	1.6×+0.6×	1×+0.4×	0.6×-4.9×	5.4×-21.1×
Leverage
Debt-to-equity	0.4×-1.1×	1.5×+1.4×	0.1×+0.1×	0×0.0×
Debt-to-assets	0.2×-0.1×	0.3×+0.3×	0×0.0×	0×0.0×
Interest coverage	-7.2×+4.6×	-11.8×+21.2×	-33×+94.0×	-127.1×-162×
Per Share
Book value per share	$2.70+215%	$0.86—	——	——
Valuation
Market capitalization	$773.23M+58.2%	$445.16M+79.3%	$248.24M+56.7%	$158.4M-48.6%
Enterprise value	$678.78M+32.5%	$471.67M+123%	$211.26M+124%	$94.27M-52.2%
Price / earnings	6.2×—	——	——	——
Price / sales	6.3×-5.7×	18.9×+9.8×	9×-6.5×	15.6×+4.8×
Price / book	3.8×-8.2×	11.2×+7.2×	4×+1.9×	2.1×-0.9×
EV / sales	5.6×-7.2×	20×+12.3×	7.7×-1.6×	9.3×+2.4×
Earnings yield	15.9%+34.5pp	-23.7%-5.2pp	-18.5%—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Zevra Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Zevra Therapeutics, Inc.'s profit margins?: Zevra Therapeutics, Inc. (ZVRA) runs a 86.1% gross margin and a -103.9% operating margin, with a 101.6% net margin.
Where do Zevra Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Zevra Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.